Target intelligence / Profile preview

Progesterone synthesis (None standard for the pathway. For the enzyme: "3β-HSD".)

Target: None standard for the pathway. For the enzyme: "3β-HSD".
Molecular classification: None for the pathway itself. Key enzymes include "Oxidoreductase (3β-HSD)", Cytochrome P450 enzyme (CYP11A1, CYP17A1, etc.)

Overview

Progesterone synthesis is the multi-step metabolic pathway by which cholesterol is converted into progesterone through enzymatic reactions, most notably by 3 beta-hydroxysteroid dehydrogenase, in tissues such as the adrenal cortex, ovaries, and placenta. The process is essential for the regulation of reproductive physiology, and imbalances or defects in this pathway can lead to various endocrine disorders or impact hormone-dependent cancers. Drugs that inhibit key enzymes can alter progesterone production and have applications in treating certain conditions or as research tools.

Other names: Progesterone biosynthesisSteroidogenesis (progesterone pathway)

Mechanism of action

For drugs targeting this process: Enzyme inhibition (e.g., CYP inhibitors block steroid hormone production)

Biological functions

Hormone biosynthesisSteroidogenesisRegulation of reproductive physiology

Disease associations

Disorders of steroidogenesis (e.g., congenital adrenal hyperplasia)Hormone-dependent cancers (e.g., breast, ovarian)Reproductive disorders

Safety considerations

Inhibition or dysregulation can lead to hormone deficiency syndromesmenstrual irregularitiesinfertilityor adrenal insufficiency

Interacting drugs

Not applicable to the pathway per se. Drugs such as ketoconazole (CYP enzyme inhibitor)

1 more in the full profile.

Biomarkers

Hormone levels such as serum progesterone17α-hydroxyprogesterone

Beyond the preview

Go deeper on Progesterone synthesis (None standard for the pathway. For the enzyme: "3β-HSD".).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progesterone synthesis (None standard for the pathway. For the enzyme: "3β-HSD".).

Explore the full profile